National Atomic Company Kazatomprom JSC (KZAP) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
21 Aug, 2026Executive summary
Global nuclear energy demand is accelerating, with 38 countries committing to triple nuclear power by 2050 and over 70 reactors under construction worldwide.
Maintains position as the world's largest natural uranium producer, accounting for 20% of global primary supply and 91% of revenue from the U3O8 segment.
Strategic focus on efficient resource use, reserve replenishment, and expansion in the nuclear fuel cycle and rare metals, with continued exploration at six key areas.
Commissioned a new processing plant at Zhalpak deposit (500 t annual capacity, expansion to 900 t planned for 2027).
Consistent dividend payments and high total shareholder return since IPO.
Financial highlights
Consolidated revenue rose 9% year-over-year to nearly KZT 718 billion in 1H 2026, driven by higher realized uranium prices.
Net profit decreased 9% to KZT 240 billion due to higher FX losses and finance costs.
Adjusted EBITDA was KZT 371 billion (+2% YoY); attributable EBITDA declined 12% to KZT 265 billion.
Group U3O8 inventory increased 23% YoY to 8,245 tU; attributable inventory 6,200 tU (+15% YoY).
C1 cash cost (attributable) increased 37% to USD 24.48/lb; all-in sustaining cash cost up 25% to USD 38.45/lb.
Outlook and guidance
2026 production guidance: 27,500–29,000 tU (100% basis); attributable production 14,500–15,500 tU.
Consolidated revenue guidance revised to KZT 2,100–2,200 billion due to KZT appreciation.
C1 cash cost guidance raised to USD 25.50–27.00/lb; all-in sustaining cash cost to USD 39.00–40.50/lb.
Capital expenditures guidance increased to KZT 435–450 billion.
Long-term uranium demand expected to remain strong, with every pound produced having a committed buyer.
Latest events from National Atomic Company Kazatomprom JSC
- Production, sales, and realized prices increased in 1H2026 amid robust uranium market demand.KZAP
Q2 2026 TU - Revenue and profit fell on lower uranium sales, but a major dividend was approved.KZAP
Q1 2026 - Production up, sales down, prices higher; 2026 guidance steady amid robust nuclear demand.KZAP
Q1 2026 TU - Record uranium output and resilient financials set the stage for higher 2026 growth.KZAP
Q4 2025 - Production and sales volumes increased in 2025, but realized prices declined year-over-year.KZAP
Q4 2025 TU - Revenue up 4.7% but net profit down on lower uranium prices and higher costs.KZAP
Q3 2025 - Revenue fell but operating profit and production rose, with strong liquidity and growth plans.KZAP
Q2 2025 - Net profit up 27% year-over-year; 2025 production guidance cut amid sulfuric acid constraints.KZAP
Q2 2024 - 2024 net profit nearly doubled on uranium price strength and one-off gains; 2025 outlook robust.KZAP
Q4 2024